Biofab ApS: Financial statements 2022
CVR: 37663220
Source: annual report 2022, Danish Business Authority
01/07/2021 – 30/06/2022
Biofab ApS (CVR 37663220) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 26,024 and a net result of DKK 6,980,532 compared with DKK 6,535,529 the year before. That is a decrease of 77.4% compared with the year before. Equity in the 2022 report amounted to DKK 80,768,961. The solvency ratio was 99.7%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 26,024
- Profit/Loss
- DKK 6,980,532
- Equity
- DKK 80,768,961
- Total Assets
- DKK 81,042,893
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 26 t. | 7 mio. | 80.8 mio. | 1 |
| 2021 | - | 115 t. | 6.5 mio. | 73.8 mio. | - |
| 2020 | - | 45 t. | 4.1 mio. | 67.4 mio. | - |
| 2019 | - | -41 t. | 6.5 mio. | 63.3 mio. | - |
| 2018 | - | -7 t. | 6.4 mio. | 56.9 mio. | - |
Official annual report
Keep an eye on Biofab ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout Biofab ApS
Biofab ApS is a Danish company of the type Anpartsselskab based in Sæby, founded in 2016. The company is registered under the industry Udlejning af erhvervsejendomme. The management consists of Kim Gregersen. The company is owned by Kim Gregersen and Emil Gregersen Frandsen. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK 55,427 and a net result of DKK 3,305,305 compared with DKK 4,710,990 the year before. Equity in the 2025 report amounted to DKK 93,497,370.